BlackRock Institutional Trust Company, N.A. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$16,742,000
+3.6%
908,921
+6.7%
0.00%
-33.3%
Q3 2016$16,164,000
+21.7%
852,106
+3.4%
0.00%
+50.0%
Q2 2016$13,285,000
+95.2%
824,113
+45.3%
0.00%
+100.0%
Q1 2016$6,806,000
-15.8%
567,173
-0.1%
0.00%0.0%
Q4 2015$8,080,000
+55.3%
567,821
+27.6%
0.00%0.0%
Q3 2015$5,202,000
+10.6%
444,970
+66.3%
0.00%0.0%
Q2 2015$4,703,000
+331.1%
267,505
+266.9%
0.00%
Q1 2015$1,091,000
+27.2%
72,916
-1.3%
0.00%
Q4 2014$858,000
-19.8%
73,862
-19.6%
0.00%
Q3 2014$1,070,00091,8250.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders